A carregar...
Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine
We summarised four pivotal Randomised Controlled Trials (RCTs) with antirheumatic drugs on the secondary prevention of cardiovascular events. The favourable effects of canakinumab and colchicine confirm (low-grade) inflammation as an independent risk factor for cardiovascular events. While colchicin...
Na minha lista:
| Publicado no: | RMD Open |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7970260/ https://ncbi.nlm.nih.gov/pubmed/33727219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2020-001560 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|